Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
74691603 | 7469160 | 3 | F | 201002 | 20160905 | 20100713 | 20160909 | EXP | PHHY2010MX43335 | NOVARTIS | 73.11 | YR | F | Y | 0.00000 | 20160909 | MD | MX | MX |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
74691603 | 7469160 | 1 | PS | ACLASTA | ZOLEDRONIC ACID | 1 | Intravenous (not otherwise specified) | 5 MG (100ML), Q12MO | 21817 | 5 | MG | SOLUTION FOR INJECTION |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
74691603 | 7469160 | 1 | Osteoporosis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
74691603 | 7469160 | HO |
74691603 | 7469160 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
74691603 | 7469160 | Central nervous system infection | |
74691603 | 7469160 | Intervertebral disc protrusion | |
74691603 | 7469160 | Pain in extremity | |
74691603 | 7469160 | Post procedural infection | |
74691603 | 7469160 | Sciatica |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
74691603 | 7469160 | 1 | 200909 | 0 |